Clinical activity of pazopanib in metastatic extraosseous ewing sarcoma

Steven Attia, Scott Heitaka Okuno, Steven Robinson, Nicholas P. Webber, Daniel J. Indelicato, Robin L. Jones, Sanjay P. Bagaria, Courtney Sherman, Kevin R. Kozak, Cherise M. Cortese, Thomas McFarland, Jonathan C. Trent, Robert G. Maki

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

We report a response to pazopanib in a 69- year-old man with heavily pre-treated metastatic extraosseous Ewing sarcoma in addition to molecular profiling of his tumor. To our knowledge, this case is the earliest to demonstrate activity of an oral multi-targeted kinase inhibitor in Ewing sarcoma. This case provides rationale for adding a Ewing sarcoma arm to SARC024, a phase II study of regorafenib, another multi-targeted kinase inhibitor, in patients with liposarcoma, osteosarcoma and Ewing and Ewing-like sarcomas (NCT02048371). This national multi-institutional study is ongoing.

Original languageEnglish (US)
Article number5992
Pages (from-to)86-88
Number of pages3
JournalRare Tumors
Volume7
Issue number2
DOIs
StatePublished - 2015

Fingerprint

Ewing's Sarcoma
Phosphotransferases
Liposarcoma
Osteosarcoma
pazopanib
Neoplasms

Keywords

  • Ewing
  • Pazopanib
  • Sarcoma

ASJC Scopus subject areas

  • Oncology
  • Histology

Cite this

Clinical activity of pazopanib in metastatic extraosseous ewing sarcoma. / Attia, Steven; Okuno, Scott Heitaka; Robinson, Steven; Webber, Nicholas P.; Indelicato, Daniel J.; Jones, Robin L.; Bagaria, Sanjay P.; Sherman, Courtney; Kozak, Kevin R.; Cortese, Cherise M.; McFarland, Thomas; Trent, Jonathan C.; Maki, Robert G.

In: Rare Tumors, Vol. 7, No. 2, 5992, 2015, p. 86-88.

Research output: Contribution to journalArticle

Attia, S, Okuno, SH, Robinson, S, Webber, NP, Indelicato, DJ, Jones, RL, Bagaria, SP, Sherman, C, Kozak, KR, Cortese, CM, McFarland, T, Trent, JC & Maki, RG 2015, 'Clinical activity of pazopanib in metastatic extraosseous ewing sarcoma', Rare Tumors, vol. 7, no. 2, 5992, pp. 86-88. https://doi.org/10.4081/rt.2015.5992
Attia, Steven ; Okuno, Scott Heitaka ; Robinson, Steven ; Webber, Nicholas P. ; Indelicato, Daniel J. ; Jones, Robin L. ; Bagaria, Sanjay P. ; Sherman, Courtney ; Kozak, Kevin R. ; Cortese, Cherise M. ; McFarland, Thomas ; Trent, Jonathan C. ; Maki, Robert G. / Clinical activity of pazopanib in metastatic extraosseous ewing sarcoma. In: Rare Tumors. 2015 ; Vol. 7, No. 2. pp. 86-88.
@article{b930630cbc9f4627a49192f4778a7558,
title = "Clinical activity of pazopanib in metastatic extraosseous ewing sarcoma",
abstract = "We report a response to pazopanib in a 69- year-old man with heavily pre-treated metastatic extraosseous Ewing sarcoma in addition to molecular profiling of his tumor. To our knowledge, this case is the earliest to demonstrate activity of an oral multi-targeted kinase inhibitor in Ewing sarcoma. This case provides rationale for adding a Ewing sarcoma arm to SARC024, a phase II study of regorafenib, another multi-targeted kinase inhibitor, in patients with liposarcoma, osteosarcoma and Ewing and Ewing-like sarcomas (NCT02048371). This national multi-institutional study is ongoing.",
keywords = "Ewing, Pazopanib, Sarcoma",
author = "Steven Attia and Okuno, {Scott Heitaka} and Steven Robinson and Webber, {Nicholas P.} and Indelicato, {Daniel J.} and Jones, {Robin L.} and Bagaria, {Sanjay P.} and Courtney Sherman and Kozak, {Kevin R.} and Cortese, {Cherise M.} and Thomas McFarland and Trent, {Jonathan C.} and Maki, {Robert G.}",
year = "2015",
doi = "10.4081/rt.2015.5992",
language = "English (US)",
volume = "7",
pages = "86--88",
journal = "Rare Tumors",
issn = "2036-3605",
publisher = "PagePress",
number = "2",

}

TY - JOUR

T1 - Clinical activity of pazopanib in metastatic extraosseous ewing sarcoma

AU - Attia, Steven

AU - Okuno, Scott Heitaka

AU - Robinson, Steven

AU - Webber, Nicholas P.

AU - Indelicato, Daniel J.

AU - Jones, Robin L.

AU - Bagaria, Sanjay P.

AU - Sherman, Courtney

AU - Kozak, Kevin R.

AU - Cortese, Cherise M.

AU - McFarland, Thomas

AU - Trent, Jonathan C.

AU - Maki, Robert G.

PY - 2015

Y1 - 2015

N2 - We report a response to pazopanib in a 69- year-old man with heavily pre-treated metastatic extraosseous Ewing sarcoma in addition to molecular profiling of his tumor. To our knowledge, this case is the earliest to demonstrate activity of an oral multi-targeted kinase inhibitor in Ewing sarcoma. This case provides rationale for adding a Ewing sarcoma arm to SARC024, a phase II study of regorafenib, another multi-targeted kinase inhibitor, in patients with liposarcoma, osteosarcoma and Ewing and Ewing-like sarcomas (NCT02048371). This national multi-institutional study is ongoing.

AB - We report a response to pazopanib in a 69- year-old man with heavily pre-treated metastatic extraosseous Ewing sarcoma in addition to molecular profiling of his tumor. To our knowledge, this case is the earliest to demonstrate activity of an oral multi-targeted kinase inhibitor in Ewing sarcoma. This case provides rationale for adding a Ewing sarcoma arm to SARC024, a phase II study of regorafenib, another multi-targeted kinase inhibitor, in patients with liposarcoma, osteosarcoma and Ewing and Ewing-like sarcomas (NCT02048371). This national multi-institutional study is ongoing.

KW - Ewing

KW - Pazopanib

KW - Sarcoma

UR - http://www.scopus.com/inward/record.url?scp=84930938424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930938424&partnerID=8YFLogxK

U2 - 10.4081/rt.2015.5992

DO - 10.4081/rt.2015.5992

M3 - Article

AN - SCOPUS:84930938424

VL - 7

SP - 86

EP - 88

JO - Rare Tumors

JF - Rare Tumors

SN - 2036-3605

IS - 2

M1 - 5992

ER -